Clinical Trial Update: Study of Tadalafil for the Treatment of Diabetic Patients With Symptoms of Upset Stomach and Delayed Stomach Emptying [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating tadalafil for symptoms of gastroparesis in diabetic patients has completed. The sponsor is Eli Lilly and Company.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroparesis

Drugs mentioned

• TADALAFIL (TADALAFIL)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Gastroparesis | Phase 2 | Status: COMPLETED